Noxopharm Banner Image


  • Ticker NOX
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Noxopharm Logo Image
  • 11-50 Employees
  • Based in Chatswood, Australia
Noxopharm is an Australian-based clinical-stage drug development company with offices in Sydney and New York. Veyonda is the first pipeline drug candidate which is being trialed as a treatment for a broad range of solid tumor cancers and for septic shock. Later generation drug candidates for large markets of unmet medical need are being developed in an active R&D program.
4.8 / 5.0 (90)

Noxopharm reports have an aggregate usefulness score of 4.8 based on 90 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Noxopharm Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!